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Abstract
It is well known that monitoring of radioactivity released from nuclear medicine departments is necessary to ensure the
radiological safety of patients and personnel. Unfortunately, equipment for air sampling is often expensive, loud and is not
suitable to use in hospitals. Our goal was to find cheap and simple system for passive monitoring of 131I activity
concentration in the air of nuclear medicine departments. Medical activated charcoal tablets were used, because charcoal is
excellent material for 131I trapping and tablets are readily available. Our proposed sampling protocol contains tablets
preparation, exposure and measurements using HPGe detector. Different methods of tablets preparation (drying,
impregnation with KI or NaOH) were tested while an experimental chamber was prepared for estimating 131I (released
from Na131I, similar to that used in therapy) trapping efficiency of tablets in different conditions. Finally, tablets were
placed in plastic holders and tested in nuclear medicine facilities.
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Introduction
In modern nuclear medicine, 131I is still one of the most
widely used radionuclides as a short-lived (T1/2 = 8.03 d,
where it’s effective half-life time in organisms is nearly
equivalent to the physical half-live [1]) beta emitter for
therapy and diagnostics of the thyroid gland. It can be used
in many chemical forms, of which Na131I is the most
popular, but other compounds such as 131I-metaiodoben-
zoguanidine and 131I-norcholesterol are also used [2].
Because activities of 131I used in medicine are very high
(up to several dozen GBq), there is an enhanced risk of
releasing 131I into the air and also to septic tanks systems
[3]. There are several ways wich 131I can be released, e. g.
opening packages with Na131I (used as a standard chemical
form of 131I wich can be administrated for patients) or
emitting gaseous 131I by patient (by breathing or perspi-
ration). The gaseous fraction can be inhaled, and 131I can
be deposited in thyroids of medical staff (technicians,
nurses and doctors). 131I has been detected in medical staff
using whole body spectrometer (WBS) and HPGe detec-
tors. Activities of 131I measured in WBS were in the range
from 5 ± 2 to 217 ± 56 Bq corresponding annual thyroid
equivalent dose ranging from 0.4 mSv (for a female nurse)
to 15.5 mSv (for a male technician) [4]. Due to these
results, measurements of airborne 131I activity were per-
formed at the Department of Endocrynology and Nuclear
Medicine Holycross Cancer Centre (E&M HCC Kielce,
Poland) where the previously measured medical staff is
worked. Results showed, that the activity of 131I in the
work space ranged from 28 ± 1 to 492 ± 4 Bq m-3
depending on location (nurses station or hot room) which
was similar to results obtained by other authors [2, 5]. With
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this levels of 131I concentration in the workplace the annual
inhalation effective dose can range from 0.47 mSv (female
nurse) to 1.3 mSv (male technician) [6]. 131I activity was
measured with a charcoal trap covered with a Petryanov
filter cloth and was connected to a mobile HVS 30 aerosol
sampler. This combination, allowed us to measure both,
aerosols (trapped on filter) and the gaseous fraction of 131I
with high efficiency. Unfortunately, this equipment is not a
good choice to be routinely used in hospitals due to the size
and noise of the unit. Therefore, we developed a passive
131I monitoring technique, similar to 222Rn monitoring with
a PicoRad system. In order to introduce a cheap and simple
system, charcoal tablets, which are readily available and
are commonly used in medicine, were used. Because
charcoals are often impregnated, (e.g. with KI or Ag salts)
some modification of tablets to compare them with non-
treated tablets were performed. This study is similar to that
presented by Jime`nez et al. [2] but the activity of 131I is
measured directly, without the chemical treatment, that is
necessary for LSC measurements. It is a practical
approach, because nuclear medicine departments are
equipped with counting systems, and therefore facilities
can make measurements independently.
Materials and methods
Charcoal tablets preparation
During the in situ experiment three methods of tablet
preparation for 131I trapping were tested. First, tablets were
impregnated in 2% solution of KI in water. The second was
impregnation of tablets with 2% NaOH solution. Both the
KI and NaOH tablets were baked at 105 C and impreg-
nated by dropping of solution onto surface of the tablets
using a plastic Pasteur pipette. After impregnation, tablets
were held at room temperature by one hour and then were
baked again for 24 h at 105 C to remove water. The third
method of tablet preparation used only baking, without any
wet impregnation.
Containers
Empty PicoRad containers were filled with dry silica gel to
reduce moisture exposure of tablets during transport and to
stabilize moisture variations during sampling. We have
used silica gel with a color indicator, which slowly
becomes greenish during exposure of the tablets at the
hospital, indicates that the silica gel still had some moisture
capacity. Dry charcoal tablets were placed into small
plastic holders with Petryanov filter cloth on the top and on
the bottom side. For each PicoRad container we have
placed two tablets. Then, containers were closed, sealed
with Parafilm and sent to the hospital for 131I collection.
Sampling and activity measurement
Patient rooms and hot rooms were chosen as a sampling
sites. In both sites we placed a set of three containers and
left them open for 1 week. After exposure, containers were
sent back to our laboratory for gamma-ray spectrometry
measurements, performed using HPGe detector with 9%
relative efficiency constructed at the Institute of Nuclear
Physics Polish Academy of Sciences. Separate measure-
ments of the tablets, silica gel and filter cloths were
performed.
Preparation of calibration chamber
The sampling system was also tested using a calibration
chamber and a system for producing tracer isotopes. Pro-
duction of tracer (126I) is possible by irradiation of non-
enriched TeO2 with a proton beam at 30 MeV (corre-
sponding to the highest cross-section for 126I [7]), using
AIC-144 cyclotron (Institute of Nuclear Physics PAS).
Activated targets are heated in the furnace up to 750 C
and gaseous iodine is trapped in 0.01 N NaOH solution.
From the basic solution, iodine can be released in gaseous
126I2 by adding concentrated HNO3. The test chamber was
prepared from a glovebox sealed with chemical-resistant
silicone and equipped with a Geiger based counting system
for detecting eventual leaks form the chamber.
Results and discussion
Results of the gamma spectrometry measurements are
presented in Table 1. There was no 131I detected on sil-
icagel or the filter cloths. The mean trapping efficiency
calculated by the simple activity ratio method ranges from
0.13 to 2.9%.
The highest activity in both sampling stations was
measured in tablet, which were baked at 105 C without
any wet treatment. The total adsorption of 131I on activated
charcoal with chemical modification is the sum of the
adsorption process on charcoal itself and chemical trapping
by the impregnating agent. In the case of KI and NaOH
impregnation these processes can be described as follows:
KI þ 131I2 ! K131I3 ð1Þ
131I2 þ 2NaOH ! Na131I þ Na131IO þ H2O ð2Þ
However, impregnation can cause a reduction of active
surface and with higher concentrations of impregnating
solution absorption will be reduced due to occupation of
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the active surface [8]. Also, the impregnation technique is
likely important. In first approach we used an impregnation
method described by Gourani et al. [9], but commercially
made medical tablets degraded in impregnating solution.
Later, we attempted to use Pasteur pipettes to gently, drop
by drop, impregnate form both sides of a tablet. However,
the results showed that ‘‘stock’’, baked-only tablets should
also be a good choice as a passive monitoring absorption
material. Further studies will show if impregnation with a
reduced concentration of impregnating solution is viable.
Another issue in the case of passive monitoring is the
calibration of the monitoring system, where it is the goal to
find the relationship between activity absorbed in the
activated charcoal and the activity concentration in air. In a
first approximation for our pilot study we have calculated
the trapping efficiency as a ratio between the activity
trapped in tablets and the activity in the air of the sampling
site as determined by conventional sampling with HVS-30
station. However, this approach is only a rough estimation,
and tablets must be tested in controlled conditions. For
future efficiency tests, we have decided to use 126I as a
tracer, because it has a half-life almost two times longer
than 131I (13.11 d) and is easy to produce on site with a
cyclotron from non-enriched targets (TeO2) using the
reaction natTe(p,xn)124,126I. Therefore transport of highly
radioactive Na131I (commercially available) is not neces-
sary. 222Rn trapping efficiency can also be used for cali-
bration, where the standard equation used for calibration of
activated charcoal detectors in a chamber is [2]:
CaV ¼ N=ðfafct kÞ ð3Þ
where Ca (Bq m
-3) is concentration inside glovebox dur-
ing calibration, V (m3) is the chamber volume, N is the
count rate of the calibrated sample (cps), fa is the trapping
efficiency (Bq m-3 cps-1), fc is the germanium spec-
trometer efficiency for the gamma line (364 keV for 131I or
666 keV for 126I), t is the charcoal exposure time in the
chamber (s) and k is the correction factor for radioactive
decay during calibration and counting (s-1) calculated as:
k ¼ kt= 1  eðk tÞ
 
ð4Þ
where k is the decay constant of 131I or 126I (depending on
the isotope used for calibration). The issue with this is that
there may be only small amounts of charcoal used in a
single container, which may only provide a weak signal in
small HPGe detectors. However, the application of ger-
manium detectors with high efficiency or with a well
geometry should give quite good results.
Conclusions
This article describes results of pilot studies about the
application of medical activated charcoal for passive
monitoring of gaseous 131I activity concentration in nuclear
medicine departments, where activity concentration of 131I
can reach levels of few hundred Bq. Conventional air
sampling methods are based on large and noisy air sam-
plers, which are not suitable for routine measurements in
hospitals. Our method is based on direct gamma-ray
measurements of 131I trapped in charcoal tablets prepared
in different ways using a HPGe detector, requiring no
chemical treatment or mixing with scintillating cocktail.
Results showed, that 131I can be trapped in both, impreg-
nated and non-impregnated tablets. Since measurements of
131I activity in air are necessary for the radioprotection of
patients and personnel after precise calibration this method
will become useful.
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